Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection

New England Journal of Medicine

Volumn 334, Issue 20, 1996, Pages 1292-1297

  Miller, George ^a   Rigsby, Michael O ^a   Heston, Lee ^a   Grogan, Elizabeth ^a   Sun, Ren ^a   Metroka, Craig ^b,d   Levy, Jay A ^c   Gao, Shou Jiang ^d   Chang, Yuan ^d   Moore, Patrick ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; POLYPEPTIDE; PROTEIN P40; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HERPES VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL, TUMOR; BIOLOGICAL MARKERS; BUTYRIC ACID; BUTYRIC ACIDS; CELL LINE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HERPESVIRIDAE; HIV INFECTIONS; HUMANS; IMMUNOBLOTTING; MALE; PREDICTIVE VALUE OF TESTS; SARCOMA, KAPOSI;

EID: 15844378212     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199605163342003     Document Type: Article

References (38)

1. Kaposi M. Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syph 1872;4:265-73.
2. Safai B, Good RA. Kaposi's sarcoma: a review and recent developments. Clin Bull 1980;10:62-9.
3. Loethe F. Kaposi's sarcoma in Ugandan Africans. Acta Pathol Microbiol Scand Suppl 1963;161:1-70.
4. Beral V. Epidemiology of Kaposi's sarcoma. Cancer Surv 1991;10:5-22. [Erratum, Cancer Surv 1992;12:225a.]
5. Penn I. Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation 1979;27:8-11.
6. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York City and California. MMWR Morb Mortal Wkly Rep 1981; 30:305-8.
7. Friedman-Kien AE, Laubenstein LJ, Rubenstein P, et al. Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med 1982;96:693-700.
8. Gordon JA. Clinical features of Kaposi's sarcoma amongst Rhodesian Africans. Cent Afr J Med 1972;19:1-6.
9. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Arch Intern Med 1994;154:566-72.
10. Giraldo G, Beth E, Huang E-S. Kaposi's sarcoma and its relationship to cytomegalovirus (CMV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer 1980;26:23-9.
11. Ambinder RF, Newman C, Hay ward GS, et al. Lack of association of cytomegalovirus with endemic African Kaposi's sarcoma. J Infect Dis 1987; 156:193-7.
12. Jahan N, Razzaque A, Greenspan J, et al. Analysis of human KS biopsies and cloned cell lines for cytomegalovirus, HIV-1, and other selected DNA virus sequences. AIDS Res Hum Retrovirus 1989;5:225-31.
13. Huang YQ, Li JJ, Rush MG, et al. HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet 1992;339:515-8.
14. Wang RY-H, Shih JW-K, Weiss SH, et al. Mycoplasma penetrans infection in male homosexuals with AIDS: high seroprevalence and association with Kaposi's sarcoma. Clin Infect Dis 1993;17:724-9.
15. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266: 1865-9.
16. Albrecht J-C, Nicholas J, Biller D, et al. Primary structure of the herpesvirus saimiri genome. J Virol 1992;66:5047-58.
17. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995;332:1181-5.
18. Su IJ, Hsu YS, Chang YC, Wang IW. Herpesvirus-like DNA sequence in Kaposi's sarcoma from AIDS and non-AIDS patients in Taiwan. Lancet 1995; 345:722-3.
19. Dupin N, Grandadam M, Calvez V, et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 1995;345:761-2.
20. Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995; 268:582-3.
21. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995;1:705-6.
22. Chang Y, Ziegler J, Wabinga H, et al. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Arch Intern Med 1996;156:202-4.
23. Boshoff C, Whitby D, Hatziioannu T, et al. Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995;345:1043-4.
24. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
25. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-80.
26. Leder A, Leder P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 1975;5:319-22.
27. Burns LJ, Glauber JG, Ginder GD. Butyrate induces selective transcriptional activation of a hypomethylated embryonic globin gene in adult erythroid cells. Blood 1988;72:1536-42.
28. Luka J, Kallin B, Klein G. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 1979;94:228-31.
29. Knowles DM, Inghirami G, Ubriaco A, Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenic role of the Epstein-Barr virus. Blood 1989;73:792-9.
30. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995;86:2708-14.
31. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993;259:946-51.
32. Miller G, Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci U S A 1973;70:190-4.
33. zur Hausen H, O'Neill FJ, Freese UK, Hecker R. Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 1978;272:373-5.
34. Rabson M, Heston L, Miller G. Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells. Proc Natl Acad Sci U S A 1983;80:2762-6.
35. Calender A, Billaud M, Aubry J-P, Banchereau J, Vuillaume M, Lenoir GM. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc Natl Acad Sci USA 1987;84:8060-4.
36. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4.
37. van Grunsven WMJ, van Heerde EC, de Haard HJW, Spaan WJM, Middeldorp JM. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins. J Virol 1993;67:3908-16.
38. Moore PS, Gao S-J, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 1996;70:549-58.